Oral Antibody Tests
COVID-19 diagnostic testing conducted in conjunction with COVID-19 antibody testing is proving to be a very effective strategy in addressing the COVID-19 response challenges faced by workplaces, educational institutions, government agencies or wherever large congregate public gatherings occur.
For host organizations (employers, educational organizations, health providers, etc.) testing for antibodies is the next logical step to help guide decisions about moving forward in the response to the COVID-19 pandemic.
Test results play a critical role in the fight against COVID-19 by identifying who has detectable antibodies. Together with other clinical information and guidance from health authorities, these results can assist with decisions on ensuring the safety of employees and customers.
The world's first and only oral swab test.
Greenwarez Global is pleased to introduce a major breakthrough in COVID-19 testing with the game-changing CovAb™ and CovAbScreen™ rapid antibody test kits. These ground-breaking advances in technology are the world’s first and only oral swab rapid antibody tests capable of detecting all three immunoglobulin neutralizing antibody classes (IgA, IgG and IgM) produced as a result of a prior COVID-19 infection or by COVID-19 vaccination.
These non-invasive premium antibody tests require no need for blood draw, nasal swabs, lab work or lab instruments. With a simple swab of the mouth these rapid antibody test can detect the presence of COVID-19 antibodies within 15 minutes.
CovAb™ has received FDA Emergency Use Authorizations (EUA) for point-of-care use in the United States.
CovAbTM Antibody Test Kit
The CovAb™ SARS-CoV-2 Antibody Test is a lateral-flow immunoassay intended for the qualitative detection of total antibody (including IgG, IgA and IgM) to SARS-CoV-2 in oral fluid from patients with suspected COVID-19 infection.
The CovAb™ SARS-CoV-2 Antibody Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating a recent or prior infection, or vaccination.
The CovAb™ SARS-CoV-2 Antibody Test is distributed and sold exclusively in the USA domestic market.
CovAb™ is a rapid Covid-19 antibody test with the following features:
- Saliva based – non invasive;
- Rapid results – 15 minutes;
- 97.6% sensitivity / 98.8% specificity*;
- Detects all 3 antibody classes (IgA, IgG, and IgM);
- FDA Emergency Use Authorization;
- Made in the USA.
*>15 days from onset of symptoms.
The world’s first and only oral swab antibody test kits.
CovAbScreenTM Antibody Test Kit
The CovAbScreen™ Antibody Test is a lateral-flow immunoassay intended for the qualitative detection of total antibody (including IgG, IgA and IgM) to SARS-CoV-2 in oral fluid from patients with suspected COVID-19 infection.
The CovAbScreen ™ SARS-CoV-2 Antibody Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating a recent or prior infection, or vaccination.
CovAbScreen™ is sold and distributed in all international (Non-USA) markets.
CovAbScreen™ is a rapid Covid-19 antibody test with the following features:
- Saliva based – non invasive;
- Rapid results – 15 minutes;
- 97.6% sensitivity / 98.8% specificity*;
- Detects all 3 antibody classes (IgA, IgG, and IgM);
- CE Mark certified;
- Made in the USA.
*>15 days from onset of symptoms.
4 Simple Steps.
